| Financial Year |
March 31 2023 |
| Monetary Funds |
1,901,874,830.04 |
| Held-for-trading Financial Assets |
147,337,382.22 |
| Notes Receivable |
1,710,725.80 |
| Accounts Receivable |
25,075,710.04 |
| Advances to Suppliers |
10,591,773.59 |
| Other Receivables |
23,132,377.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,312,143.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
53,418,087.18 |
| Other Current Assets |
11,509,473.34 |
| Total Current Assets |
2,226,023,743.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
58,488,665.45 |
| Investment Properties |
21,986,179.71 |
| Fixed Assetes |
456,209,446.64 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,925,605.47 |
| R&D expenses |
13,770,216.74 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,298,590.75 |
| Deferred Income Tax Assets |
35,464,276.77 |
| Other Non-Current Assets |
12,617,081.26 |
| Sub-Total of Non-Current Assets |
1,263,431,641.74 |
| Total Assets |
3,489,455,385.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
105,829,153.64 |
| Accounts Received In Advance |
20,807.33 |
| Employee Compensation Payable |
52,086,050.18 |
| Taxes Payable |
24,278,600.43 |
| Interest Payable |
-- |
| Dividend Payable |
280,167,477.30 |
| Other payables |
334,176,385.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,892,416.57 |
| Other Current Liabilities |
1,830,993.19 |
| Sub-Total of Current Liabilities |
1,264,438,290.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
143,888.23 |
| Deferred Income Tax Liabilities |
25,459,318.85 |
| Other Non-Current Liabilities |
142,319,334.16 |
| Sub-Total of Non-Current Liabilities |
190,022,832.36 |
| Total Liabilities |
1,454,461,122.56 |
| Paid-In Capital(Or Share Stock) |
311,297,197.00 |
| Capital Surplus |
1,152,891,305.72 |
| Surplus Reserve |
155,425,903.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
345,901,030.27 |
| Minority Stockholder's Interest |
15,230,361.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,019,763,901.15 |
| Owner's Equity（Stockholder's Equity） |
2,034,994,262.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,489,455,385.23 |
